V
511509
vs
B
BSE Sensex 30
Over the past 12 months, VIVOBIOT has underperformed BSE Sensex 30, delivering a return of -25% compared to the BSE Sensex 30's +9% growth.
Stocks Performance
511509 vs BSE Sensex 30
Performance Gap
511509 vs BSE Sensex 30
Performance By Year
511509 vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Vivo Bio Tech Ltd
Glance View
Vivo Bio Tech Ltd. engages in the provision of drug development and discovery services. The company is headquartered in Hyderabad, Telangana. The firm provides services of in-vitro, in-vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. The firm's services are offered to pharma, biotech and Agri companies, which include molecular biology services, the fermentation process of E.Coli harboring the plasmid containing the gene of interest, protein purification, bioassay, Physico-chemical and biochemical/immunological characterization of various proteins. The firm's In-vivo services provide preclinical testing services in rodents/non-rodents, and canines. The firm's subsidiaries include Vivobio Labs Private Ltd, Vivobio Discovery services Private Ltd, Surlogic Life Consultancy Private Ltd and Vivobio Consulting Services Private Ltd.
